Swiss pharma giant Roche announced some very promising results for its weight loss drug from a recent clinical trial. The anti-obesity medication, called CT-388, has even outperformed market leaders like Wegovy and Ozempic. Here’s all you need to know about the medicine.
Discover more from The Doon Mozaic
Subscribe to get the latest posts to your email.